Cargando…

Antitumor necrosis factor-α antibodies as a noveltherapy for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) accounts for many cases of cancer-associated mortality. Tumor necrosis factor (TNF)-α is a key mediator of tumor-promoting inflammation. It has been demonstrated that anti-TNF-α treatments have preclinical benefits for multiple types of cancer, however their potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Jian, Yong-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090380/
https://www.ncbi.nlm.nih.gov/pubmed/30116311
http://dx.doi.org/10.3892/etm.2018.6235

Ejemplares similares